You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Relapsed or Refractory Acute Lymphoblastic Leukemia

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Refractory Acute Lymphoblastic Leukemia, Relapsed Acute Lymphoblastic Leukemia Trial in Miami (Pevonedistat, Vincristine,

Completed
  • Refractory Acute Lymphoblastic Leukemia
  • Relapsed Acute Lymphoblastic Leukemia
  • Miami, Florida
    University of Miami
Oct 19, 2022

Acute Lymphoblastic Leukemia Trial in Sanhe (CAR-NK-CD19 Cells)

Completed
  • Acute Lymphoblastic Leukemia
  • CAR-NK-CD19 Cells
  • Sanhe, Hebei, China
    Hebei Yanda Ludaopei Hospital
Nov 24, 2022

Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphoblastic Leukemia With Failed Remission Trial in São Paulo (Bortezomib)

Not yet recruiting
  • Acute Lymphoblastic Leukemia, in Relapse
  • Acute Lymphoblastic Leukemia With Failed Remission
  • São Paulo, SP, Brazil
    Instituto do Cancer do Estado de Sao Paulo
Sep 12, 2023

Relapsed/Refractory Acute Lymphoblastic Leukemia, T-cell Acute Lymphoblastic Leukemia Trial in France

Recruiting
  • Relapsed/Refractory Acute Lymphoblastic Leukemia
  • T-cell Acute Lymphoblastic Leukemia
    • Amiens, France
    • +30 more
    Apr 14, 2023

    T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma Trial (CD7-CART01)

    Not yet recruiting
    • T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
    • CD7-CART01
    • (no location specified)
    Sep 26, 2023

    B-cell Acute Lymphoblastic Leukemia Trial (HY004, Cyclophosphamide, Fludarabine Phosphate)

    Not yet recruiting
    • B-cell Acute Lymphoblastic Leukemia
    • HY004
    • +2 more
    • (no location specified)
    Aug 18, 2023

    B Precursor Acute Lymphoblastic Leukemia, Relapsed/Refractory B Precursor Acute Lymphoblastic Leukemia Trial (Blinatumomab)

    Not yet recruiting
    • B Precursor Acute Lymphoblastic Leukemia
    • Relapsed/Refractory B Precursor Acute Lymphoblastic Leukemia
    • (no location specified)
    Sep 25, 2023

    B-cell Acute Lymphoblastic Leukemia Trial in Hefei (QH103 Cell Injection, Fludarabine, Cyclophosphamide)

    Recruiting
    • B-cell Acute Lymphoblastic Leukemia
    • QH103 Cell Injection
    • +2 more
    • Hefei, Anhui, China
      Anhui Provincial Hospital
    Sep 21, 2023

    B-cell Acute Lymphoblastic Leukemia Trial (CD19-CAR_Lenti_ALLO)

    Not yet recruiting
    • B-cell Acute Lymphoblastic Leukemia
    • (no location specified)
    Oct 10, 2023

    Refractory B-cell Acute Lymphoblastic Leukemia Trial in Houston (Mosunetuzumab)

    Not yet recruiting
    • Refractory B-cell Acute Lymphoblastic Leukemia
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 18, 2023

    Acute Lymphoblastic Leukemia, Immune System Diseases, Immunoproliferative Disorders Trial in Chapel Hill (iC9-CAR19 cells,

    Recruiting
    • Acute Lymphoblastic Leukemia
    • +2 more
    • iC9-CAR19 cells
    • +3 more
    • Chapel Hill, North Carolina
      Lineberger Comprehensive Cancer Center at University of North Ca
    Dec 21, 2022

    PET-CT Imaging in Relapsed/Refractory Acute Leukemias

    Not yet recruiting
    • B Cell
    • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Aug 4, 2023

      Leukemia Trial in Boston, Houston (Venetoclax, Standard Chemotherapy)

      Recruiting
      • Leukemia
      • Chicago, Illinois
      • +2 more
      Oct 3, 2022

      Acute Lymphoblastic Leukemia Trial (inotuzumab ozogamicin)

      Not yet recruiting
      • Acute Lymphoblastic Leukemia
      • inotuzumab ozogamicin
      • (no location specified)
      Jan 6, 2023

      B-cell Acute Lymphoblastic Leukemia, B-cell Lymphoma, Diffuse Large B Cell Lymphoma Trial in Beijing (CD19/CD22-bispecific CAR-T

      Recruiting
      • B-cell Acute Lymphoblastic Leukemia
      • +2 more
      • CD19/CD22-bispecific CAR-T cells
      • Beijing, Beijing, China
        Liang Wang
      Oct 7, 2023

      T-Cell Acute Lymphocytic Leukemia Trial in Langfang (CD7 CAR-T)

      Recruiting
      • T-Cell Acute Lymphocytic Leukemia
      • CD7 CAR-T
      • Langfang, Hebei, China
        Hebei Yanda Hospital
      Jun 26, 2023

      Acute T-lymphoblastic Leukemia, Acute T-lymphoblastic Lymphoma Trial in Xuzhou (CAR-T Cell Infusion)

      Recruiting
      • Acute T-lymphoblastic Leukemia
      • Acute T-lymphoblastic Lymphoma
      • CAR-T Cell Infusion
      • Xuzhou, Jiangsu, China
        The Affiliated Hospital of Xuzhou Medical University
      Feb 23, 2023

      T-Acute Lymphoblastic Leukemia, Adult T Lymphoblastic Lymphoma Trial in United States (BL-8040, Nelarabine)

      Terminated
      • T-Acute Lymphoblastic Leukemia
      • Adult T Lymphoblastic Lymphoma
      • Saint Louis, Missouri
      • +1 more
      Jan 18, 2023

      T-cell Acute Lymphoblastic Leukemia/Lymphoma Trial in Beijing (Senl-T7)

      Recruiting
      • T-cell Acute Lymphoblastic Leukemia/Lymphoma
      • Senl-T7
      • Beijing, Hebei, China
        Hebei yanda Hospital
      Nov 22, 2022

      B-Cell Non Hodgkin Lymphoma, B-Cell Acute Lymphoblastic Leukemia Trial in Hanoi (anti-CD19 CAR T-cells)

      Recruiting
      • B-Cell Non Hodgkin Lymphoma
      • B-Cell Acute Lymphoblastic Leukemia
      • anti-CD19 CAR T-cells
      • Hanoi, Vietnam
        Vinmec Research Institute of Stem Cell and Gene Technology
      Sep 5, 2023

      Lymphoblastic Lymphoma, T-Cell Lymphoblastic Leukemia/Lymphoma, Lymphoblastic Leukemia Trial in Philadelphia (BEAM-201)

      Recruiting
      • Lymphoblastic Lymphoma
      • +2 more
      • BEAM-201
      • Philadelphia, Pennsylvania
        Children's Hospital of Philadelphia
      Jun 2, 2023

      CAR, Refractory Acute Lymphoblastic Leukemia, Relapsed Adult ALL Trial in Suzhou (Treatment)

      Recruiting
      • CAR
      • +2 more
      • Suzhou, Jiangsu, China
        The First Affiliated Hospital of Soochow University
      Dec 27, 2022

      Allogeneic Hematopoietic Stem Cell Transplantation, Acute Lymphoblastic Leukemia Trial in Suzhou (VEN+AZA+Modified BUCY)

      Recruiting
      • Allogeneic Hematopoietic Stem Cell Transplantation
      • Acute Lymphoblastic Leukemia
      • VEN+AZA+Modified BUCY
      • Suzhou, Jiangsu, China
        The First Affiliated Hospital of Soochow University
      Apr 10, 2023

      Lymphoid Leukemia, Acute Lymphoblastic Leukemia, Refractory Acute Lymphoblastic Leukemia Trial in Tampa (CPX-351)

      Active, not recruiting
      Has Results
      • Lymphoid Leukemia
      • +3 more
      • Tampa, Florida
        H. Lee Moffitt Cancer Center and Research Institute
      Dec 30, 2022

      Acute Lymphoblastic Leukemia (ALL) Trial (Nilotinib)

      No longer available
      • Acute Lymphoblastic Leukemia (ALL)
      • (no location specified)
      Aug 5, 2022